Medical Device Cybersecurity in the Age of IoMT

By Mo Madinejad, Irdeto

As the proliferation of connected and complex medical devices grows, healthcare providers are more susceptible to cyberattacks.

MEDdesign

Patent and Regulatory Challenges in AI’s Use
in Life Sciences

By Emily Rapalino, Cindy Chang, and Nicholas Mitrokostas,
Goodwin Procter, LLP

With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.

Will Digital Health Technology Play a Role
in Traveler Safety?

By Maria Fontanazza, Editor-in-Chief

Having the ability to assess vital signs in real time could be the future of monitoring the health of travelers to help prevent outbreaks.

Featured Quote

Evolving regulatory requirements such as EU MDR and IVDR, as well as compounding downstream effects of the FDA’s Medical Device Single Audit Program, add further complexity to the PMS process and increase potential for surveillance inspections post-pandemic.

— Carl Ning, Veeva Systems

Soapbox

Electronic Product Information:
A Roadmap to the Business Benefits

By Agnes Cwienczek, AMPLEXOR

Digital technologies offer more efficient and patient-friendly distribution of the up-to-date manufacturing details and safety advice mandated by regulators. But many firms in the medtech sector are not maximizing the opportunity to deliver regulated product information digitally.

COVID-19 Will Forever Change MedTech and Healthcare

By Maria Fontanazza

Medtech companies will need to collaborate more closely with other parties in healthcare, as the aftermath of the coronavirus pandemic will have a comprehensive reach throughout the entire ecosystem. MedTech Intelligence speaks with Johnson & Johnson VP Raymond Fryrear, M.D. on the topic.

Soapbox

2020 Business Outlook:
Five Macrotrends Changing the Way Medtech Does Business

By Adrienne Lovink, Lexie Code and Zaid Al-Nassir, Decision Resources Group

In recent years, global medtech markets have been dominated by some key overarching drivers: Growing efforts to reduce healthcare costs, an increasing interest in value-based care—reflected by heightened emphasis on patient safety and efficacious treatment approaches—and expanded opposition to barriers to entry, whether from technical trade barriers or a lack of regulatory harmonization.

• Medical Device Audits, Certification & Verification
• Quality & Regulatory Market Access Solutions
  sponsored by UL
• Medical Device Component
  sponsored by 3M
• Medical Recall